Generics 36

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tobramycin sulfate manufacturers

36 products found

Filters

36 products found

tobramycin sulfate

Vials, injection 1,2g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #1187

tobramycin sulfate

Vials, injection 40 mg/ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

tobramycin sulfate + dexamethasone sodium phosphate + benzalkonium chloride

Ear/eye drops 0.3 %+0.1 %+0.02 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

tobramycin sulfate + benzalkonium chloride

Ear/eye drops 0.3 %+0.02 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

tobramycin sulfate

Ear/eye drops 0.3% W/V

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273

Manufacturer usually replies in 1 days

tobramycin sulfate

Solution for injection 80 mg/2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

tobramycin sulfate + benzalkonium chloride

Eye drops 0.3 % + 0.2 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

tobramycin sulfate

Eye drops 0.3 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

Manufacturer usually replies in 9 days

tobramycin sulfate

Ear/eye drops 0.3 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20259

Manufacturer usually replies in 9 days

tobramycin sulfate

Injection 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20122

Manufacturer usually replies in 7 days

tobramycin sulfate + dexamethasone sodium phosphate

Eye drops 3 mg/ml + 1 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #16167

Manufacturer usually replies in 7 days

tobramycin sulfate + moxifloxacin hydrochloride

Eye drops 0.3% + 0.5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO
Manufacturer #18135

Manufacturer usually replies in 12 days

tobramycin sulfate + dexamethasone sodium phosphate

Eye drops 0.5 % + 0.1 % - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #2693

Manufacturer usually replies in 5 days

tobramycin sulfate

Eye drops 0.3 % - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #2693

Manufacturer usually replies in 5 days

tobramycin sulfate

Injection 1.2g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #8101

Manufacturer usually replies in 27 days

tobramycin sulfate

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

tobramycin sulfate

Eye drops 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

tobramycin sulfate + dexamethasone sodium phosphate + benzalkonium chloride

Eye drops 0.3 %+0.1 %+0.02 %, 0.3 %+0.05 %+0.02 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

tobramycin sulfate + fluorometholone + hydroxyprophylmethylcellulose

Eye drops 0.3 %+0.1 %+0.7 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

tobramycin sulfate + fluorometholone + benzalkonium chloride

Eye drops 0.3 %+0.1 %+0.02 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

Want to view all 36 products? Create your free account today!

Tobramycin sulfate:

Tobramycin is an aminoglycoside broad-spectrum antibiotic derived from Streptomyces tenebrarius. Being an antibiotic, it is used as a medication in the treatment of many types of bacterial infections. With it being partially effective against gram-negative bacteria and those of the species Pseudomonas. Tobramycin was originally isolated and subsequently patented by a pharmaceutical products manufacturing company in 1965 and was approved for medical use in 1974. Currently, it has entered into the generic drugs space. Making it cost-efficient and attractive for tobramycin manufacturers and tobramycin suppliers to list for sale. It is widely found across the global medical marketplace ready to order wholesale on the pharmaceutical products list of distributors, at a variety of cost and price points.

Method of action of tobramycin sulfate:

Tobramycin functions through the inhibition of bacterial protein synthesis. This is enabled by its ability to irreversibly bind to one of two aminoglycoside binding sites on the bacterial 30 S ribosomal subunit, the cellular component responsible for protein manufacturing. Tobramycin may also act to destabilize the bacterial membrane through action on the 16 s ribosome RNA. If proteins cannot be synthesized, new bacterial components cannot be made, and subsequent cell death will follow.

Form and dosage of tobramycin sulfate:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific order and distributors. However, tobramycin can typically be found for wholesale order in forms including injection, solution for injection, vials, ampules, and eye drops. For the treatment of local eye infections, it should be applied 2-4 times a day depending on severity. For injection or infusion, the recommended dose is 3 mg/kg daily in 3 divided doses. These are guidelines and the specific dose amounts will vary greatly on patient-specific factors. For further information please contact a healthcare provider or refer to the manufacturers’ literature.

Tobramycin sulfate on Pipelinepharma:

Currently, at the time of writing, we have found 3 verified tobramycin manufacturers and tobramycin suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries including China, India, and Vietnam. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of tobramycin sulfate and how to buy:

A cursory search online reveals an approximate cost for wholesale tobramycin to be £19.20 for 40 mg per 1 ml of 6ml vials. These values are indicated exclusively for the NHS in the UK using the drug tariff Part VIIIA Category C. As such they are only intended to serve as a generalization of the current market conditions in a specific area and a specific form.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.